Associated Papers
Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC.
He P et al.
Frontiers in Oncology, 2023
36910641 (PubMed )
Supplement: DataSheet_1.xlsx › Table_S8
Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk.
Fu R et al.
Translational Lung Cancer Research, 2022
35529798 (PubMed )
Supplement: tlcr-11-04-509-supplementary.pdf
Select a paper to view details